Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Alex on +44 1494 818021 or alex@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Alex Reynolds
Account Manager
alex@zenopa.com
+44 1494 818021

Testimonials
Thanks very much to the Zenopa team for all your help with finding me my great new position! You made my job search so easy by finding the vacancies, sending my CV.
Tom, 2011

Sanofi-aventis to launch blood glucose monitoring devices

21 September 2010 00:00 in Pharmacy Supplier News


Sanofi-aventis is to launch two new blood glucose monitoring devices which are designed to make it easier for diabetes sufferers to self-manage their conditions.

The new BGStar and iBGStar units have been developed in association with AgaMatrix and utilise Dynamic Electrochemistry technology to provide reliable readings, as well as a clear display and numerous feedback features.

In addition, patients can connect the iBGStar to their iPhone or iPod touch units, where they can perform testing and share data with their doctors using the iBGStar Diabetes Manager App.

According to Pierre Chancel, senior vice-president of the global diabetes division of Sanofi-aventis, this will allow users to fit their diabetes care into their daily routines more easily.

"It is an important step toward our goal of delivering seamless connectivity between diagnostics, treatment and monitoring," he added.

The company's diabetes offering also includes the SoloSTAR and reusable ClikSTAR pen-based drug administration devices, as well as treatments such as Lantus and Apidra.ADNFCR-8000103-ID-800074577-ADNFCR

Other news stories from 21/09/2010

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



   
© Copyright 2013 Zenopa Ltd